For treatment of benign prostatic hyperplasia (BPH), transurethral Holmium Laser Enucleation of the Prostate (HoLEP) has emerged as the new gold standard. Compared to other familiar BPH procedures, HoLEP has lower morbidity, less blood loss, more comfortable recovery, a shorter hospital stay, less time with a catheter, and lower retreatment rates.